Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717027 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
A Phase 1 study, sponsored by Pain Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT01717027 is a Phase 1 study that has completed, run by Pain Therapeutics. The registered enrollment target is 19 participants.
The verdict
NCT01717027, a Phase 1 study, has completed, sponsored by Pain Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
To estimate the pharmacokinetics and relative bioavailability of oxycodone after administration of 40 mg doses of PF-00345439 formulations taken whole under fed conditions and after chewing under fasted conditions in healthy volunteers
Interventions
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01717027
The ClinicalTrials.gov registry entry for NCT01717027 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pain Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxycodone is the first listed.
NCT01717027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01717027 about?
NCT01717027 is a clinical study titled "Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers". To estimate the pharmacokinetics and relative bioavailability of oxycodone after administration of 40 mg doses of PF-00345439 formulations taken whole under fed conditions and after chewing under fasted conditions in healthy volunteers
What is the current status of trial NCT01717027?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2012-11. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01717027?
The interventions under investigation include: Oxycodone (DRUG).
Who is sponsoring clinical trial NCT01717027?
This trial is sponsored by Pain Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.